{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:35:04Z","timestamp":1791578104351,"version":"4.3.4"},"reference-count":82,"publisher":"Society of Nuclear Medicine","issue":"Supplement 1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.2967\/jnumed.121.263196","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T16:11:10Z","timestamp":1654099870000},"page":"20S-26S","source":"Crossref","is-referenced-by-count":139,"title":["Tau PET Imaging in Neurodegenerative Disorders"],"prefix":"10.2967","volume":"63","author":[{"given":"Colin","family":"Groot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Villeneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"2022060616200900000_63.Supplement_1.20S.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0173(00)00019-9"},{"key":"2022060616200900000_63.Supplement_1.20S.2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.neuro.24.1.1121"},{"key":"2022060616200900000_63.Supplement_1.20S.3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3233\/JAD-122059","article-title":"Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807","volume":"34","author":"Chien","year":"2013","journal-title":"J Alzheimers Dis."},{"key":"2022060616200900000_63.Supplement_1.20S.4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00259-020-05118-w","article-title":"Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer\u2019s disease in the context of a structured 5-phase biomarker development framework","volume":"48","author":"Wolters","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200900000_63.Supplement_1.20S.5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s00259-021-05277-4","article-title":"Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"48","author":"Chiotis","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200900000_63.Supplement_1.20S.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2013.07.037"},{"key":"2022060616200900000_63.Supplement_1.20S.7","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201707809"},{"key":"2022060616200900000_63.Supplement_1.20S.8","doi-asserted-by":"crossref","first-page":"7350","DOI":"10.1021\/acs.jmedchem.7b00632","article-title":"Identification of three novel radiotracers for imaging aggregated tau in Alzheimer\u2019s disease with positron emission tomography","volume":"60","author":"Gobbi","year":"2017","journal-title":"J Med Chem."},{"key":"2022060616200900000_63.Supplement_1.20S.9","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.116.185199"},{"key":"2022060616200900000_63.Supplement_1.20S.10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","article-title":"Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue","volume":"7","author":"Aguero","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"2022060616200900000_63.Supplement_1.20S.11","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1007\/s00259-020-05156-4","article-title":"Clinical validity of second-generation tau PET tracers as biomarkers for Alzheimer\u2019s disease in the context of a structured 5-phase development framework","volume":"48","author":"Bischof","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200900000_63.Supplement_1.20S.12","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm104"},{"key":"2022060616200900000_63.Supplement_1.20S.13","doi-asserted-by":"crossref","first-page":"631\u2013639","DOI":"10.1212\/WNL.42.3.631","article-title":"Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer\u2019s disease","volume":"42","author":"Arriagada","year":"1992","journal-title":"Neurology."},{"key":"2022060616200900000_63.Supplement_1.20S.14","doi-asserted-by":"publisher","DOI":"10.1097\/NEN.0b013e31825018f7"},{"key":"2022060616200900000_63.Supplement_1.20S.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2014.05.004"},{"key":"2022060616200900000_63.Supplement_1.20S.16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","article-title":"An autoradiographic evaluation of AV-1451 tau PET in dementia","volume":"4","author":"Lowe","year":"2016","journal-title":"Acta Neuropathol Commun."},{"key":"2022060616200900000_63.Supplement_1.20S.17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24517"},{"key":"2022060616200900000_63.Supplement_1.20S.18","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","article-title":"Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer\u2019s disease, primary tauopathies, and other dementias","volume":"12","author":"Sander","year":"2016","journal-title":"Alzheimers Dement."},{"key":"2022060616200900000_63.Supplement_1.20S.19","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","article-title":"Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue","volume":"7","author":"Aguero","year":"2019","journal-title":"Acta Neuropathol Commun."},{"key":"2022060616200900000_63.Supplement_1.20S.20","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-018-0342-8"},{"key":"2022060616200900000_63.Supplement_1.20S.21","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1001\/jamaneurol.2020.2526","article-title":"Assessment of 18F-PI-2620 as a biomarker in progressive supranuclear palsy","volume":"77","author":"Brendel","year":"2020","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.22","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","article-title":"High-contrast in\u00a0vivo imaging of tau pathologies in Alzheimer\u2019s and non-Alzheimer\u2019s disease tauopathies","volume":"109","author":"Tagai","year":"2021","journal-title":"Neuron."},{"key":"2022060616200900000_63.Supplement_1.20S.23","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron emission tomography imaging with [18F]flortaucipir and postmortem assessment of Alzheimer disease neuropathologic changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.24","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer\u2019s disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain."},{"key":"2022060616200900000_63.Supplement_1.20S.25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","article-title":"Tau-positron emission tomography correlates with neuropathology findings","volume":"16","author":"Lowe","year":"2020","journal-title":"Alzheimers Dement."},{"key":"2022060616200900000_63.Supplement_1.20S.26","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13550-020-00653-x","article-title":"Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer\u2019s disease pathology: a clinicopathological study","volume":"10","author":"Pontecorvo","year":"2020","journal-title":"EJNMMI Res."},{"key":"2022060616200900000_63.Supplement_1.20S.27","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","article-title":"Correlation of in\u00a0vivo [18F]flortaucipir with postmortem Alzheimer disease tau pathology","volume":"76","author":"Smith","year":"2019","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.28","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww163"},{"key":"2022060616200900000_63.Supplement_1.20S.29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0470-7","article-title":"18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes","volume":"11","author":"Tsai","year":"2019","journal-title":"Alzheimers Res Ther."},{"key":"2022060616200900000_63.Supplement_1.20S.30","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1212\/WNL.0000000000004364","article-title":"18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome","volume":"89","author":"Cho","year":"2017","journal-title":"Neurology."},{"key":"2022060616200900000_63.Supplement_1.20S.31","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1212\/WNL.0000000000004264","article-title":"In vivo retention of 18F-AV-1451 in corticobasal syndrome","volume":"89","author":"Smith","year":"2017","journal-title":"Neurology."},{"key":"2022060616200900000_63.Supplement_1.20S.32","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00401-016-1618-1","article-title":"[18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration","volume":"132","author":"Josephs","year":"2016","journal-title":"Acta Neuropathol (Berl)."},{"key":"2022060616200900000_63.Supplement_1.20S.33","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00401-016-1640-3","article-title":"Multimodal evaluation demonstrates in\u00a0vivo 18F-AV-1451 uptake in autopsy-confirmed corticobasal degeneration","volume":"132","author":"McMillan","year":"2016","journal-title":"Acta Neuropathol (Berl)."},{"key":"2022060616200900000_63.Supplement_1.20S.34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/mds.26844","article-title":"Subcortical 18F-AV-1451 binding patterns in progressive supranuclear palsy","volume":"32","author":"Cho","year":"2017","journal-title":"Mov Disord."},{"key":"2022060616200900000_63.Supplement_1.20S.35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/mds.26813","article-title":"Increased basal ganglia binding of 18F-AV-1451 in patients with progressive supranuclear palsy","volume":"32","author":"Smith","year":"2017","journal-title":"Mov Disord."},{"key":"2022060616200900000_63.Supplement_1.20S.36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/mds.26834","article-title":"[18F]AV-1451 tau positron emission tomography in progressive supranuclear palsy","volume":"32","author":"Whitwell","year":"2017","journal-title":"Mov Disord."},{"key":"2022060616200900000_63.Supplement_1.20S.37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00401-019-02121-w","article-title":"[18F]flortaucipir distinguishes Alzheimer\u2019s disease from progressive supranuclear palsy pathology in a mixed-pathology case","volume":"139","author":"Smith","year":"2020","journal-title":"Acta Neuropathol (Berl)."},{"key":"2022060616200900000_63.Supplement_1.20S.38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00401-016-1650-1","article-title":"Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy","volume":"133","author":"Smith","year":"2017","journal-title":"Acta Neuropathol (Berl)."},{"issue":"4","key":"2022060616200900000_63.Supplement_1.20S.39","doi-asserted-by":"crossref","first-page":"fcab190","DOI":"10.1093\/braincomms\/fcab190","article-title":"Evaluation of [18F]PI-2620, a second-generation selective tau tracer, for assessing four-repeat tauopathies","volume":"3","author":"Tezuka","year":"2021","journal-title":"Brain Commun."},{"key":"2022060616200900000_63.Supplement_1.20S.40","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/mds.26961","article-title":"In vivo cortical tau in Parkinson\u2019s disease using 18F-AV-1451 positron emission tomography","volume":"32","author":"Hansen","year":"2017","journal-title":"Mov Disord."},{"key":"2022060616200900000_63.Supplement_1.20S.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04496-0"},{"key":"2022060616200900000_63.Supplement_1.20S.42","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.254961"},{"key":"2022060616200900000_63.Supplement_1.20S.43","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.209650"},{"key":"2022060616200900000_63.Supplement_1.20S.44","doi-asserted-by":"crossref","first-page":"102708","DOI":"10.1016\/j.nicl.2021.102708","article-title":"Sex differences in off-target binding using tau positron emission tomography","volume":"31","author":"Smith","year":"2021","journal-title":"Neuroimage Clin."},{"key":"2022060616200900000_63.Supplement_1.20S.45","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.224113"},{"key":"2022060616200900000_63.Supplement_1.20S.46","doi-asserted-by":"crossref","first-page":"118259","DOI":"10.1016\/j.neuroimage.2021.118259","article-title":"Selecting software pipelines for change in flortaucipir SUVR: balancing repeatability and group separation","volume":"238","author":"Schwarz","year":"2021","journal-title":"Neuroimage."},{"key":"2022060616200900000_63.Supplement_1.20S.47","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.dib.2017.10.024","article-title":"Considerations and code for partial volume correcting [18F]-AV-1451 tau PET data","volume":"15","author":"Baker","year":"2017","journal-title":"Data Brief."},{"key":"2022060616200900000_63.Supplement_1.20S.48","doi-asserted-by":"crossref","first-page":"117193","DOI":"10.1016\/j.neuroimage.2020.117193","article-title":"Compensating for choroid plexus based off-target signal in the hippocampus using 18F-flortaucipir PET","volume":"221","author":"Pawlik","year":"2020","journal-title":"Neuroimage."},{"key":"2022060616200900000_63.Supplement_1.20S.49","doi-asserted-by":"crossref","first-page":"102113","DOI":"10.1016\/j.nicl.2019.102113","article-title":"Hippocampal [18F]flortaucipir BPND corrected for possible spill-in of the choroid plexus retains strong clinico-pathological relationships","volume":"25","author":"Wolters","year":"2020","journal-title":"Neuroimage Clin."},{"key":"2022060616200900000_63.Supplement_1.20S.50","doi-asserted-by":"crossref","first-page":"118553","DOI":"10.1016\/j.neuroimage.2021.118553","article-title":"ADNI. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [18F]-AV-1451 PET data","volume":"243","author":"Young","year":"2021","journal-title":"Neuroimage."},{"key":"2022060616200900000_63.Supplement_1.20S.51","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.200006"},{"key":"2022060616200900000_63.Supplement_1.20S.52","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.245423"},{"key":"2022060616200900000_63.Supplement_1.20S.53","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2017.05.058"},{"key":"2022060616200900000_63.Supplement_1.20S.54","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1349-0"},{"key":"2022060616200900000_63.Supplement_1.20S.55","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4669"},{"key":"2022060616200900000_63.Supplement_1.20S.56","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jama.2018.12917","article-title":"Discriminative accuracy of [18F]flortaucipir positron emission tomography for Alzheimer disease vs other neurodegenerative disorders","volume":"320","author":"Ossenkoppele","year":"2018","journal-title":"JAMA."},{"key":"2022060616200900000_63.Supplement_1.20S.57","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww027"},{"key":"2022060616200900000_63.Supplement_1.20S.58","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med."},{"key":"2022060616200900000_63.Supplement_1.20S.59","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00259-020-05152-8","article-title":"Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts","volume":"48","author":"Provost","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200900000_63.Supplement_1.20S.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2008.11.007"},{"key":"2022060616200900000_63.Supplement_1.20S.61","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018"},{"key":"2022060616200900000_63.Supplement_1.20S.62","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1001\/jamaneurol.2021.1858","article-title":"Accuracy of tau positron emission tomography as a prognostic marker in preclinical and prodromal Alzheimer disease","volume":"78","author":"Ossenkoppele","year":"2021","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.63","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.biopsych.2020.01.023","article-title":"Amyloid and tau pathology associations with personality traits, neuropsychiatric symptoms, and cognitive lifestyle in the preclinical phases of sporadic and autosomal dominant Alzheimer\u2019s disease","volume":"89","author":"Pichet Binette","year":"2021","journal-title":"Biol Psychiatry."},{"key":"2022060616200900000_63.Supplement_1.20S.64","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.221697"},{"key":"2022060616200900000_63.Supplement_1.20S.65","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awz090","article-title":"A multicentre longitudinal study of (18F)flortaucipir in normal ageing, mild cognitive impairment and Alzheimer\u2019s disease dementia","volume":"142","author":"Pontecorvo","year":"2019","journal-title":"Brain."},{"key":"2022060616200900000_63.Supplement_1.20S.66","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13195-021-00880-x","article-title":"Tau-PET and in\u00a0vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals","volume":"13","author":"Biel","year":"2021","journal-title":"Alzheimers Res Ther."},{"key":"2022060616200900000_63.Supplement_1.20S.67","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamaneurol.2020.5505","article-title":"Aggregated tau measured by visual interpretation of flortaucipir positron emission tomography and the associated risk of clinical progression of mild cognitive impairment and Alzheimer disease: results from 2 phase III clinical trials","volume":"78","author":"Lu","year":"2021","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.68","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aau5732"},{"key":"2022060616200900000_63.Supplement_1.20S.69","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-981-32-9358-8_18","article-title":"Tau PET imaging","volume":"1184","author":"Higuchi","year":"2019","journal-title":"Adv Exp Med Biol."},{"key":"2022060616200900000_63.Supplement_1.20S.70","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awz268"},{"key":"2022060616200900000_63.Supplement_1.20S.71","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00259-021-05401-4","article-title":"A multicenter comparison of [18F]flortaucipir, [18F]RO948, and [18F]MK6240 tau PET tracers to detect a common target ROI for differential diagnosis","volume":"48","author":"Leuzy","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2022060616200900000_63.Supplement_1.20S.72","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1212\/WNL.0000000000004887","article-title":"Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease","volume":"90","author":"Mattsson","year":"2018","journal-title":"Neurology."},{"key":"2022060616200900000_63.Supplement_1.20S.73","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic performance of F18-RO948 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.74","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phospho-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA."},{"key":"2022060616200900000_63.Supplement_1.20S.75","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww027"},{"key":"2022060616200900000_63.Supplement_1.20S.76","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","article-title":"Four distinct trajectories of tau deposition identified in Alzheimer\u2019s disease","volume":"27","author":"Vogel","year":"2021","journal-title":"Nat Med."},{"key":"2022060616200900000_63.Supplement_1.20S.77","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic performance of 18F-RO948 tau positron emission tomography in the differentiation of Alzheimer disease from other neurodegenerative disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurol."},{"key":"2022060616200900000_63.Supplement_1.20S.78","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1093\/brain\/awaa180","article-title":"18F-MK-6240 PET for early and late detection of neurofibrillary tangles","volume":"143","author":"Pascoal","year":"2020","journal-title":"Brain."},{"key":"2022060616200900000_63.Supplement_1.20S.79","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1038\/s41598-019-42625-9","article-title":"18F-flortaucipir in TDP-43 associated frontotemporal dementia","volume":"9","author":"Smith","year":"2019","journal-title":"Sci Rep."},{"key":"2022060616200900000_63.Supplement_1.20S.80","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bpa.12486","article-title":"Frontotemporal lobar degeneration: pathogenesis, pathology and pathways to phenotype","volume":"27","author":"Mann","year":"2017","journal-title":"Brain Pathol."},{"key":"2022060616200900000_63.Supplement_1.20S.81","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/alz.12356","article-title":"Towards clinical application of tau PET tracers for diagnosing dementia due to Alzheimer\u2019s disease","volume":"17","author":"Ossenkoppele","year":"2021","journal-title":"Alzheimers Dement."},{"key":"2022060616200900000_63.Supplement_1.20S.82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2013.06.001"}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.121.263196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T23:22:47Z","timestamp":1654557767000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.121.263196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":82,"journal-issue":{"issue":"Supplement 1","published-online":{"date-parts":[[2022,6,1]]},"published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10.2967\/jnumed.121.263196"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.121.263196","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]}}}